This grant proposal seeks to determine the mechanisms underlying the development of neuropathic pain in association with HIV-1 infection and its treatment with Nucleoside Reverse Transcriptase Inhibitors (NRTIs). We observed that receptors for CHEMOtactic cytoKINES (chemokines) are expressed by cells in the Dorsal Root Ganglia under different circumstances. Under normal conditions CXCR4, the receptors for the chemokine SDF-1/CXCL12, are expressed by DRG neurons and glia. SDF-1 is also constitutively expressed. Other types of chemokines and their receptors are not normally expressed by these cells. We observed that in several rodent models of neuropathic pain the expression of certain chemokines such as MCP- 1/CCL2 and their receptors such as CCR2, is greatly increased by DRG neurons and glia. Following their upregulation by DRG neurons, chemokines are packaged into synaptic vesicles and can be released from DRG neurons by depolarizing stimuli and from glial cells in a Ca dependent fashion. DRG neurons from animals with neuropathic pain are strongly depolarized by chemokines such as MCP-1. We have observed that treatment of peripheral nerves with the HIV-1 envelope protein gp120 produces increased expression of MCP-1/CCR2 in the DRG in association with neuropathic pain. We also observed that treatment of rodents with NRTIs produces neuropathic pain and that this is associated with upregulation of CXCR4 receptors in DRG neurons and glia. Inhibition of CXCR4 function inhibits NRTI associated pain hypersensitivity. Narrative: In this grant proposal we shall determine- 1) The relative roles of glial and neuronal CXCR4 expression in the development of NRTI induced pain hypersensitivity. 2) The role of CXCR4 receptor upregulation in the DRG in the synergistic effects of NRTIs and HIV-1 infection in producing pain hypersensitivity. 3) The role of chemokines as novel neurotransmitters in the DRG in producing neuropathic pain. The proposed studies will help us to understand how infection with HIV-1 and treatment with anti-HIV-1 drugs produces chronic pain syndromes. The resulting data will suggest novel approaches to the treatment of these disorders.
| Belmadani, Abdelhak; Ren, Dongjun; Bhattacharyya, Bula J et al. (2015) Identification of a sustained neurogenic zone at the dorsal surface of the adult mouse hippocampus and its regulation by the chemokine SDF-1. Hippocampus 25:1224-41 |
| Bhattacharyya, Bula J; Wilson, Scott M; Jung, Hosung et al. (2012) Altered neurotransmitter release machinery in mice deficient for the deubiquitinating enzyme Usp14. Am J Physiol Cell Physiol 302:C698-708 |
| Banisadr, Ghazal; Bhattacharyya, Bula J; Belmadani, Abdelhak et al. (2011) The chemokine BRAK/CXCL14 regulates synaptic transmission in the adult mouse dentate gyrus stem cell niche. J Neurochem 119:1173-82 |
| Wilson, Natalie M; Jung, Hosung; Ripsch, Matthew S et al. (2011) CXCR4 signaling mediates morphine-induced tactile hyperalgesia. Brain Behav Immun 25:565-73 |
| White, Fletcher; Wilson, Natalie (2010) Opiate-induced hypernociception and chemokine receptors. Neuropharmacology 58:35-7 |
| White, Fletcher A; Miller, Richard J (2010) Insights into the regulation of chemokine receptors by molecular signaling pathways: functional roles in neuropathic pain. Brain Behav Immun 24:859-65 |
| Bhangoo, Sonia K; Ripsch, Matthew S; Buchanan, David J et al. (2009) Increased chemokine signaling in a model of HIV1-associated peripheral neuropathy. Mol Pain 5:48 |
| Abbadie, Catherine; Bhangoo, Sonia; De Koninck, Yves et al. (2009) Chemokines and pain mechanisms. Brain Res Rev 60:125-34 |
| White, Fletcher A; Feldman, Polina; Miller, Richard J (2009) Chemokine signaling and the management of neuropathic pain. Mol Interv 9:188-95 |
| Miller, Richard J; Jung, Hosung; Bhangoo, Sonia K et al. (2009) Cytokine and chemokine regulation of sensory neuron function. Handb Exp Pharmacol :417-49 |
Showing the most recent 10 out of 26 publications
